Hearing Practitioner Australia·Regulatory·Tinnitus·5d agoFDA approves BosSTENT trial for pulsatile tinnitusIf the BosSTENT pivotal trial succeeds, it could establish the first purpose-built interventional device for venous sinus stenosis–related pulsatile tinnitus, expanding the treatment pathway beyond audiology into neurovascular care.
Hearing Health Matters·Press release·Tinnitus·5w agoSonorous Neurovascular Receives FDA Authorization for Pulsatile Tinnitus Stent TrialIf successful, this pivotal trial could establish the first dedicated device-based treatment pathway for cerebral venous sinus-related pulsatile tinnitus, a condition with very limited current options.+Save
Hearing Health Matters·Press release·Tinnitus·3mo agoSonorous Neurovascular Enrolls First Canadian Patient in B-SILENT Pulsatile Tinnitus StudyPulsatile tinnitus linked to narrowed brain blood vessels (cerebral venous sinus stenosis) has very limited treatment options, and a dedicated implant trial could open a new interventional pathway if results are positive.+Save